{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:24:24Z","timestamp":1793330664480,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Epidemiology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.annepidem.2026.110081","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T15:56:40Z","timestamp":1774108600000},"page":"110081","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Latent tuberculosis infection care cascade outcomes in primary care clinics in the tuberculosis epidemiologic studies consortium-III"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9781-5748","authenticated-orcid":false,"given":"Laura A.","family":"Vonnahme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Ravindhran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Espey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhumika","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaylynn","family":"Aiona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Skarbinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Narita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya B.","family":"Shete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagadheeswari","family":"Adhimurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Broadhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Bond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Murrill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Chieh","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meagan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Winglee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.annepidem.2026.110081_bib1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.15585\/mmwr.mm7112a1","article-title":"Tuberculosis - United States, 2021","volume":"71","author":"Filardo","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"10.1016\/j.annepidem.2026.110081_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.15585\/mmwr.mm7312a4","article-title":"Tuberculosis \u2014 United States, 2023","volume":"73","author":"Williams","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.annepidem.2026.110081_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/aje\/kwt246","article-title":"Horsburgh CR. Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup","author":"Shea","year":"2014","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.annepidem.2026.110081_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153728","article-title":"Recent Transmission of Tuberculosis \u2014 United States, 2011\u20132014","volume":"11","author":"Yuen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.annepidem.2026.110081_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/aje\/kwy094","article-title":"Prospects for tuberculosis elimination in the United States: Results of a transmission dynamic model","author":"Menzies","year":"2018","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.annepidem.2026.110081_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/j.1440-1843.2010.01751.x","article-title":"Treatment of latent tuberculosis infection: An update","author":"Lobue","year":"2010","journal-title":"Respirology"},{"key":"10.1016\/j.annepidem.2026.110081_bib7","article-title":"Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020","author":"Sterling","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep Publ Online"},{"issue":"4","key":"10.1016\/j.annepidem.2026.110081_bib8","first-page":"555","article-title":"Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis","volume":"60","author":"International Union Against Tuberculosis Committee on Prophylaxis","year":"1982","journal-title":"Bull World Health Organ"},{"issue":"9","key":"10.1016\/j.annepidem.2026.110081_bib9","doi-asserted-by":"crossref","first-page":"e3468","DOI":"10.1093\/cid\/ciaa1662","article-title":"Prevalence of Latent Tuberculosis Infection Among Non-US-Born Persons by Country of Birth-United States, 2012-2017","volume":"73","author":"Collins","year":"2021","journal-title":"Clin Infect Dis Publ Infect Dis Soc Am"},{"key":"10.1016\/j.annepidem.2026.110081_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciw778","article-title":"Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children","author":"Lewinsohn","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.annepidem.2026.110081_bib11","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2016.11046","article-title":"Screening for Latent Tuberculosis Infection in Adults: U.S. Preventive Services Task Force Recommendation Statement","volume":"316","author":"US Preventive Services Task Force","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.annepidem.2026.110081_bib12","article-title":"Latent Tuberculosis","year":"2020","journal-title":"Infect A Guide Prim Health Care Provid"},{"issue":"4","key":"10.1016\/j.annepidem.2026.110081_bib13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10903-022-01438-1","article-title":"Can Primary Care Drive Tuberculosis Elimination? Increasing Latent Tuberculosis Infection Testing and Treatment Initiation at a Community Health Center with a Large Non-U.S.-born Population","volume":"25","author":"Tang","year":"2023","journal-title":"J Immigr Minor Heal"},{"issue":"4","key":"10.1016\/j.annepidem.2026.110081_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.focus.2023.100148","article-title":"Using Electronic Health Record Data to Measure the Latent Tuberculosis Infection Care Cascade in Safety-Net Primary Care Clinics","volume":"2","author":"Vonnahme","year":"2023","journal-title":"AJPM Focus"},{"key":"10.1016\/j.annepidem.2026.110081_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(16)30216-X","article-title":"The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis","author":"Alsdurf","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.annepidem.2026.110081_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad219","article-title":"Latent Tuberculosis Infection Treatment Practices in Two Large Integrated Health Systems in California, 2009\u20132018","volume":"10","author":"Bruxvoort","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"12","key":"10.1016\/j.annepidem.2026.110081_bib17","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1001\/jamainternmed.2017.3941","article-title":"Cost-effectiveness of Testing and Treatment for Latent Tuberculosis Infection in Residents Born Outside the United States With and Without Medical Comorbidities in a Simulation Model","volume":"177","author":"Tasillo","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.annepidem.2026.110081_bib18","doi-asserted-by":"crossref","first-page":"756","DOI":"10.31128\/AJGP-10-23-6988","article-title":"Models of care for tuberculosis infection screening and treatment in primary care: A scoping review","volume":"53","author":"Chatterji","year":"2024","journal-title":"Aust J Gen Pr"},{"issue":"4","key":"10.1016\/j.annepidem.2026.110081_bib19","doi-asserted-by":"crossref","first-page":"432","DOI":"10.5588\/ijtld.16.0575","article-title":"Improved latent tuberculosis therapy completion rates in refugee patients through use of a clinical pharmacist","volume":"21","author":"Carter","year":"2017","journal-title":"Int J Tube Lung Dis J Int Union Tube Lung Dis"},{"issue":"3","key":"10.1016\/j.annepidem.2026.110081_bib20","first-page":"79","article-title":"Tuberculosis screening in an at-risk immigrant Hispanic population in Baltimore city: an academic health center\/local health department partnership","volume":"9","author":"D\u2019Lugoff","year":"2002","journal-title":"J Cult Divers"},{"issue":"3","key":"10.1016\/j.annepidem.2026.110081_bib21","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s10903-020-01047-w","article-title":"Programmatic Effectiveness of Latent Tuberculosis Care Cascade in a Community Health Center","volume":"23","author":"Prater","year":"2021","journal-title":"J Immigr Minor Heal"},{"issue":"3","key":"10.1016\/j.annepidem.2026.110081_bib22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.amepre.2004.12.012","article-title":"Using computerized clinical decision support for latent tuberculosis infection screening","volume":"28","author":"Steele","year":"2005","journal-title":"Am J Prev Med"},{"issue":"10","key":"10.1016\/j.annepidem.2026.110081_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110645","article-title":"Tuberculosis Treatment Managed by Providers outside the Public Health Department: Lessons for the Affordable Care Act","volume":"9","author":"Ehman","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.annepidem.2026.110081_bib24","article-title":"Measuring and improving the quality of tuberculosis care: A framework and implications from the Lancet Global Health Commission","volume":"16","author":"Arsenault","year":"2019","journal-title":"J Clin Tube Other Mycobact Dis"},{"issue":"11","key":"10.1016\/j.annepidem.2026.110081_bib25","doi-asserted-by":"crossref","first-page":"e1196","DOI":"10.1016\/S2214-109X(18)30386-3","article-title":"High-quality health systems in the Sustainable Development Goals era: time for a revolution","volume":"6","author":"Kruk","year":"2018","journal-title":"Lancet Glob Heal"},{"key":"10.1016\/j.annepidem.2026.110081_bib26","first-page":"ciac248","article-title":"Evaluation of the Latent Tuberculosis Care Cascade Among Public Health Clinics in the United States","author":"Holzman","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.annepidem.2026.110081_bib27","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.3201\/eid2609.191391","article-title":"Latent Tuberculosis Screening Using Electronic Health Record Data","volume":"26","author":"Jenks","year":"2020","journal-title":"Emerg Infect Dis J"},{"key":"10.1016\/j.annepidem.2026.110081_bib28","series-title":"Novel Tools to Measure Latent Tuberculosis Infection Among Populations at Higher Risk in the United States","author":"Vonnahme","year":"2024"},{"key":"10.1016\/j.annepidem.2026.110081_bib29","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-publhealth-031914-122747","article-title":"Uses of Electronic Health Records for Public Health Surveillance to Advance Public Health","author":"Birkhead","year":"2015","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.annepidem.2026.110081_bib30","unstructured":"Centers for Disease Control and Prevention (CDC). Tuberculosis Epidemiologic Studies Consortium. Published 2024. Accessed June 12, 2024. \u3008https:\/\/www.cdc.gov\/tb\/research\/tbesc.html\u3009."},{"key":"10.1016\/j.annepidem.2026.110081_bib31","doi-asserted-by":"crossref","DOI":"10.3201\/eid2603.190974","article-title":"U.S. tuberculosis rates among persons born outside the United States compared with rates in their countries of birth, 2012-2016","author":"Tsang","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"10.1016\/j.annepidem.2026.110081_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243102","article-title":"Interferon gamma release assay tests are associated with persistence and completion of latent tuberculosis infection treatment in the United States: Evidence from commercial insurance data","volume":"15","author":"Stockbridge","year":"2020","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.annepidem.2026.110081_bib33","first-page":"E25","article-title":"Tuberculosis Prevention in the Private Sector: Using Claims-Based Methods to Identify and Evaluate Latent Tuberculosis Infection Treatment With Isoniazid Among the Commercially Insured","volume":"24","author":"Stockbridge","year":"2018","journal-title":"J Public Health Manag Pr"},{"issue":"4","key":"10.1016\/j.annepidem.2026.110081_bib34","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s10903-020-01065-8","article-title":"Estimated Latent Tuberculosis Infection Prevalence and Tuberculosis Reactivation Rates Among Non-U.S.-Born Residents in the United States, from the 2011-2012 National Health and Nutrition Examination Survey","volume":"23","author":"Yelk Woodruff","year":"2021","journal-title":"J Immigr Minor Heal"},{"issue":"11","key":"10.1016\/j.annepidem.2026.110081_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140881","article-title":"Tuberculosis Infection in the United States: Prevalence Estimates from the National Health and Nutrition Examination Survey, 2011-2012","volume":"10","author":"Miramontes","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.annepidem.2026.110081_bib36","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201508-1683OC","article-title":"The prevalence of latent tuberculosis infection in the United States","author":"Mancuso","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.annepidem.2026.110081_bib37","doi-asserted-by":"crossref","DOI":"10.3201\/eid2510.190439","article-title":"Factoring prior treatment into tuberculosis infection prevalence estimates, United States, 2011-2012","author":"Vonnahme","year":"2019","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.annepidem.2026.110081_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249012","article-title":"State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity","volume":"16","author":"Mirzazadeh","year":"2021","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.annepidem.2026.110081_bib39","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad303","article-title":"Latent Tuberculosis Screening Cascade for Non\u2013US-Born Persons in a Large Health System","volume":"10","author":"Shapiro","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.annepidem.2026.110081_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193432","article-title":"Private sector tuberculosis prevention in the US: Characteristics associated with interferon-gamma release assay or tuberculin skin testing","volume":"13","author":"Stockbridge","year":"2018","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.annepidem.2026.110081_bib41","doi-asserted-by":"crossref","first-page":"684","DOI":"10.5588\/ijtld.16.0617","article-title":"Tuberculin skin test and interferon-gamma release assay use among privately insured persons in the United States","volume":"21","author":"Owusu-Edusei","year":"2017","journal-title":"Int J Tube Lung Dis J Int Union Tube Lung Dis"},{"key":"10.1016\/j.annepidem.2026.110081_bib42","doi-asserted-by":"crossref","DOI":"10.1378\/chest.09-0394","article-title":"Latent TB infection treatment acceptance and completion in the United States and Canada","author":"Horsburgh","year":"2010","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.annepidem.2026.110081_bib43","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.2105\/AJPH.2014.302287","article-title":"Postarrival Tuberculosis Screening of High-Risk Immigrants at a Local Health Department","volume":"105","author":"Nuzzo","year":"2015","journal-title":"Am J Public Health"},{"issue":"4","key":"10.1016\/j.annepidem.2026.110081_bib44","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1353\/hpu.2015.0126","article-title":"Improving Treatment Completion Rates for Latent Tuberculosis Infection: A Review of Two Treatment Regimens at a Community Health Center","volume":"26","author":"Lines","year":"2015","journal-title":"J Health Care Poor Under"},{"issue":"2","key":"10.1016\/j.annepidem.2026.110081_bib45","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.amepre.2018.04.030","article-title":"Isoniazid-Rifapentine for Latent Tuberculosis Infection: A Systematic Review and Meta-analysis","volume":"55","author":"Njie","year":"2018","journal-title":"Am J Prev Med"},{"issue":"7","key":"10.1016\/j.annepidem.2026.110081_bib46","doi-asserted-by":"crossref","first-page":"706","DOI":"10.5588\/ijtld.19.0792","article-title":"Diagnostic code agreement for electronic health records and claims data for tuberculosis","volume":"24","author":"Iqbal","year":"2020","journal-title":"Int J Tube Lung Dis J Int Union Tube Lung Dis"},{"issue":"6","key":"10.1016\/j.annepidem.2026.110081_bib47","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1177\/003335491012500611","article-title":"Real-time surveillance for tuberculosis using electronic health record data from an ambulatory practice in eastern Massachusetts","volume":"125","author":"Calderwood","year":"2010","journal-title":"Public Health Rep"}],"container-title":["Annals of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279726000797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279726000797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T02:41:39Z","timestamp":1776912099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047279726000797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":47,"alternative-id":["S1047279726000797"],"URL":"https:\/\/doi.org\/10.1016\/j.annepidem.2026.110081","relation":{},"ISSN":["1047-2797"],"issn-type":[{"value":"1047-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Latent tuberculosis infection care cascade outcomes in primary care clinics in the tuberculosis epidemiologic studies consortium-III","name":"articletitle","label":"Article Title"},{"value":"Annals of Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annepidem.2026.110081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110081"}}